North America Injection Pen Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)

No. of Pages: 130    |    Report Code: BMIRE00028198    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Injection Pen Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Injection Pen Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Injection Pen Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Higher Prevalence of Chronic Disorders Boosting Market Growth
5.2 Market Opportunities
  • 5.2.1 Increasing Biologics Patent Expiry and Use of Biosimilars Generating the Demand for Injection Pens
5.3 Future Trends
  • 5.3.1 Strategic Developments by Various Players Favouring Market Growth
5.4 Impact of Drivers and Restraints

6. North America Injection Pen Market Regional Analysis

6.1 North America Injection Pen Market Overview
6.2 North America Injection Pen Market Revenue 2020-2028 (US$ Million)
6.3 North America Injection Pen Market Forecast Analysis

7. North America Injection Pen Market Analysis – by Type

7.1 Disposable Injection Pens
  • 7.1.1 Overview
  • 7.1.2 Disposable Injection Pens: North America Injection Pen Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reusable Injection Pens
  • 7.2.1 Overview
  • 7.2.2 Reusable Injection Pens: North America Injection Pen Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Injection Pen Market Analysis – by Therapy

8.1 Diabetes
  • 8.1.1 Overview
  • 8.1.2 Diabetes: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Growth Hormone Therapy
  • 8.2.1 Overview
  • 8.2.2 Growth Hormone Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Autoimmune Diseases
  • 8.3.1 Overview
  • 8.3.2 Autoimmune Diseases: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Fertility
  • 8.4.1 Overview
  • 8.4.2 Fertility: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer
  • 8.5.1 Overview
  • 8.5.2 Cancer: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others Therapy
  • 8.6.1 Overview
  • 8.6.2 Others Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Injection Pen Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Others Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Home Care
  • 9.2.1 Overview
  • 9.2.2 Others Therapy: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Injection Pen Market – North America Analysis

10.1 North America
  • 10.1.1 North America Injection Pen Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Injection Pen Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Injection Pen Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Injection Pen Market Breakdown, by Therapy
    • 10.1.1.1.3 US: North America Injection Pen Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Injection Pen Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Injection Pen Market Breakdown, by Therapy
    • 10.1.1.2.3 Canada: North America Injection Pen Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Injection Pen Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Injection Pen Market Breakdown, by Therapy
    • 10.1.1.3.3 Mexico : North America Injection Pen Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Injection Pen Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eli Lilly and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Gerresheimer AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Haselmeier GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novo Nordisk AS
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Owen Mumford Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sanofi SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. AstraZeneca Plc
  2. Becton Dickinson and Co
  3. Eli Lilly and Co
  4. Gerresheimer AG
  5. Haselmeier GmbH
  6. Merck KGaA
  7. Novo Nordisk AS
  8. Owen Mumford Ltd
  9. Sanofi SA
  10. Teva Pharmaceutical Industries Ltd
north-america-injection-pen-market